Calvet X et al. |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study. |
2000 |
Helicobacter |
pmid:10672052
|
Dammann HG et al. |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. |
2000 |
Helicobacter |
pmid:10672051
|
Miyabayashi H et al. |
Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori. |
2000 |
Helicobacter |
pmid:10672049
|
Griffith DE et al. |
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. |
2000 |
Clin. Infect. Dis. |
pmid:10671330
|
Mordi MN et al. |
Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. |
2000 |
J. Med. Chem. |
pmid:10669574
|
Hoshi T et al. |
Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis. |
1999 |
Hum. Pathol. |
pmid:10667417
|
Yatsunami J et al. |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. |
1999 |
Cancer Lett. |
pmid:10660084
|
Allevi P et al. |
A new convenient transformation of erythromycin A into clarithromycin. |
1999 |
Bioorg. Med. Chem. |
pmid:10658579
|
Alarcón T et al. |
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. |
2000 |
J. Clin. Microbiol. |
pmid:10655418
|
Chiba N and Marshall CP |
Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori. |
2000 |
Can. J. Gastroenterol. |
pmid:10655024
|
Fock KM et al. |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651664
|
Wong BC et al. |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651663
|
Graham DY et al. |
Furazolidone combination therapies for Helicobacter pylori infection in the United States. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651662
|
Miyanohara T et al. |
Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. |
2000 |
Laryngoscope |
pmid:10646728
|
Keiser P et al. |
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. |
1999 |
Int J STD AIDS |
pmid:10639059
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Chan FK et al. |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632651
|
Gasbarrini A et al. |
Efficacy of a multistep strategy for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632649
|
Cammarota G et al. |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632648
|
Vcev A et al. |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632647
|
Bardhan KD et al. |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632646
|
Fujioka T |
Clarithromycin resistance in Helicobacter pylori: implications for therapy. |
2000 |
J. Gastroenterol. |
pmid:10632546
|
Hoshiya S et al. |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. |
2000 |
J. Gastroenterol. |
pmid:10632534
|
Juurlink DN and Ito S |
Comment: clarithromycin-digoxin interaction. |
1999 |
Ann Pharmacother |
pmid:10630847
|
Burgess DS et al. |
A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. |
1999 |
Ann Pharmacother |
pmid:10630825
|
Bortolotti M et al. |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1999 |
Dig. Dis. Sci. |
pmid:10630494
|
Cammarota G et al. |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. |
1999 |
Dig. Dis. Sci. |
pmid:10630486
|
Blondon H |
[Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?]. |
1999 |
Presse Med |
pmid:10629694
|
Bui KQ et al. |
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. |
2000 |
J. Antimicrob. Chemother. |
pmid:10629013
|
Lugannani C and Strickland C |
Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? |
1999 |
J Fam Pract |
pmid:10628582
|
Rocha RT et al. |
Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections. |
1999 |
Int. J. Clin. Pract. |
pmid:10622070
|
Maeda S et al. |
Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay. |
2000 |
J. Clin. Microbiol. |
pmid:10618089
|
Gotoda T et al. |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. |
1999 |
J. Gastroenterol. |
pmid:10616774
|
Aoyama N et al. |
Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers. |
1999 |
J. Gastroenterol. |
pmid:10616772
|
Kiyota K et al. |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. |
1999 |
J. Gastroenterol. |
pmid:10616771
|
Abe S et al. |
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. |
2000 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10615065
|
Midolo PD et al. |
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614963
|
Giacometti A et al. |
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614961
|
Suzuki K et al. |
Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages. |
2000 |
FEMS Microbiol. Lett. |
pmid:10612733
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Ku YY et al. |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. |
1999 |
J. Antibiot. |
pmid:10604761
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Hamada K et al. |
Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601798
|
Tanaka G et al. |
Effect of clarithromycin on Pseudomonas aeruginosa biofilms. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601796
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Raderer M et al. |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. |
2000 |
Gut |
pmid:10601069
|
Feldman M et al. |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. |
1999 |
Am. J. Physiol. |
pmid:10600812
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Uygun A et al. |
The effect of Helicobacter pylori eradication on duodenal gastric metaplasia. |
1999 Jul-Aug |
J. Int. Med. Res. |
pmid:10599027
|
Gomollón F et al. |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. |
1999 |
Helicobacter |
pmid:10597390
|